Collegium Pharmaceutical Inc.
COLL
|
|
| |
|
| Trading Volume | 13,443 |
|
|
40.91 - 21.16 |
| Market Cap Full | $ 1.2B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 3.2% | 26% | 3.4% | 8.9% |
| Q2 | - | -16.7% | -10.4% | -12.9% |
| Q3 | - | -0.6% | 4% | -9.6% |
| Q4 | - | -6.3% | 35.2% | 44.8% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.2 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 7.1 | 11.4 | 5.7 | -10.3 | -4.7 | -2.3 | 19.1 | -0.6 | - | - | - | - |
| 2023 | |||||||||||
| 21 | -5.5 | -9.6 | -3 | -5.2 | -2.6 | 5.9 | 2.9 | -4.6 | -2.6 | 17.8 | 20.1 |
| 2022 | |||||||||||
| -5 | 13.9 | 0.6 | -20.9 | -3 | 13.4 | -3 | 2.3 | -8.9 | 12 | 21.9 | 6.1 |
| 2021 | |||||||||||
| 23.2 | -4.4 | 0.5 | -5.9 | 8.7 | -2.5 | 5.3 | -17.5 | -3.9 | -0.6 | -10.7 | 6.5 |
| 2020 | |||||||||||
| -0.6 | 9.8 | -26.1 | 26.6 | 6.6 | -20.6 | -9.8 | 20.8 | 9.2 | -15.4 | 6.3 | 7.1 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.5 | -0.4 | 0.4 | 0 |
| Q2 | 0.3 | -0.2 | 1.8 | 0.2 |
| Q3 | 0.5 | 0 | 0.2 | 0.3 |
| Q4 | 0 | -0.2 | -0.6 | 0.2 |
| A | 0.36 | -0.7 | 1.9 | 0.8 |